by Madaline Spencer | Aug 2, 2024
John Carmichael, MD, Co-director of the USC Pituitary Center and Clinical Chief for the Division of Endocrinology, discusses an analysis of growth hormone replacement therapy in patients under the age of 60 years. Growth hormone deficiency (GHD) is a...
by CheckRare Staff | Aug 1, 2024
« Prev1 / 1Next »CTCL: Shortening the Diagnostic Journey and Starting Treatment Early (Full Interview)CTCL Overview (Chapter 1)Treatment Plans for CTCL (Chapter 2)CTCL: The Role of the Dermatologist in Caring for Patients (Chapter 3)Global Care...
by Scott Harwood | Jul 31, 2024
Fadi Fakhouri, MD, PhD, Professor of Nephrology at Lausanne University, discusses the results from a phase 2 clinical trial testing the safety and efficacy of pegcetacoplan in patients with C3G and IC-MPGN. Complement 3 glomerulopathy (C3G) and...
by Madaline Spencer | Jul 29, 2024
Patty Ketting, Executive Director of the HypoPARAthyroidism Association and a patient with hypoparathyroidism, discusses challenges of hypoparathyroidism. Hypoparathyroidism is is a rare endocrine disorder in which the parathyroid glands in the neck do...
by CheckRare Staff | Jul 26, 2024
« Prev1 / 1Next »CTCL: The Role of Dermatologists in Diagnosing and Caring for Patients (Full Interview)Challenges of Diagnosing CTCL (Chapter 1)The Role of the Dermatologist in Diagnosing and Caring for CTCL Patients (Chapter 2)Ensuring the Patient Is at...
